GLOBALFOUNDRIES Inc., a semiconductor foundry, provides range of mainstream wafer fabrication services and technologies in the United States, Europe, the Middle East, Africa, and internationally.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 9.53, read 2026-11-03
Ethical passes the values gate
Price42.89 USD
Fair value46.61
Ethical score89.6/100
Value readFairas of 3 Nov 2026
Our investment reviews on this name
2026-10-28Read Distribution48.76-12.0% to today ✓Markdown gives way to Distribution
2026-10-21Read Markdown48.76-12.0% to today ✓Accumulation gives way to Markdown
2026-10-14Read Accumulation48.24-11.1% to today Markup gives way to Accumulation with deal news in the headlines
2026-10-02Read Markup47.78-10.2% to today Distribution gives way to Markup after a 10% slide in 9 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
GlobalFoundries holds its Distribution at $42.89. Elevated stress, defensive posture warranted, held for 39 days.
As held on the ledger · 2026-11-03
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 39 days
Price at the screen
$42.89
Valuation
35.82 trailing · 17.44 forward price to earnings
Values screen
PASS· score 89.6
Beta
1.77
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
9.96%
Below 33%
Interest-bearing debt is just 10.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
10.55%
Below 33%
Cash held in interest-bearing accounts and securities is 10.6% of assets, under the one-third limit.
Pass
Receivables
0.69%
Below 49%
Money owed to the company is 0.7% of assets, under the 49% limit.
Pass
Revenue purity
0.97%
Below 5%
Only 1.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
GlobalFoundries clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 10%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when GFS's ethical verdict changes
Today GFS passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 3 Nov 2026: it trades at roughly an 8% discount to our $46.61 fair value, 5.80% revenue growth.
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. A 8.0% discount to the base estimate.
Where our models see it going: fair-value estimate $46.61, with a range of $43.20 to $53.60, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Chip Foundry Price Exceeds Fair Value
Every new phone and electric car still needs chips made somewhere, yet this foundry’s modest 3 percent revenue growth sits behind a 22.8 times forward multiple. Our fair value sits 12 percent lower than the current price, so the shares offer no margin of safety. We pass.
Profit margins of 11 percent and a 7 percent return on equity look ordinary in a business that rises and falls with every tech cycle. Low multiples in cyclical sectors often flag peak earnings rather than bargains, and here the multiple is not low. Analyst targets near 80 dollars overlook that pattern.
Capacity utilisation can fall fast when orders slow, and the sector has delivered painful drawdowns before. The ethical screen is clear but the valuation is not.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GFS trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Distribution$42.89+2.6%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Distribution$41.82-0.2%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Distribution$41.90+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Distribution$41.90+0.0%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Distribution$41.90-8.6%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Distribution$45.85-0.6%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Distribution$46.11-5.4%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown · changed$48.76+1.1%Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 110% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (20 analysts) rates it buy, with a mean price target of $79.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
